人类抗体库的深度挖掘识别了频繁且基因多样化的CDRH3拓,可通过疫苗接种准
bioRxiv : the preprint server for biology
|December 3, 2025
概括
研究人员开发了一种针对特定抗体结构的新疫苗策略,以对抗艾滋病毒. 这种方法成功地在动物模型中产生了广泛中和的抗体,为更有效的艾滋病毒疫苗铺平了道路.
科学领域:
- 免疫学 免疫学 免疫学
- 结构生物学 结构生物学
- 疫苗设计 疫苗设计
背景情况:
- 开发有效的艾滋病毒疫苗是具有挑战性的,因为病毒的高可变性.
- 广泛中和抗体 (bnAbs) 是艾滋病毒疫苗策略的关键目标.
- 艾滋病毒Env蛋白的V2顶部是bnAbs的关键目标.
研究的目的:
- 调查针对HIV疫苗开发的抗体互补性确定区域3 (CDRH3) 中特定结构特征的潜力.
- 描述和量化人类抗体库中的"斧头样"CDRH3结构.
- 设计和测试能够激活这些特定CDRH3前体的新型免疫原体.
主要方法:
- 结构生物信息学和免疫信息学方法被用于分析人类抗体库.
- 新型免疫原因的设计基于HIV Env V2顶部结构.
- 使用冷电子显微镜 (cryo-EM) 确定结合相互作用.
- 免疫原性在人性化小鼠和 rhesus macaques 中进行了评估.
主要成果:
- 对于bnAbs来说重要的"斧头样"CDRH3结构在近90%的人类捐赠者中被发现.
- 设计的免疫原因有效地与这些"斧头样"CDRH3前体结合.
- 接种疫苗诱导了小鼠的V2顶端特异性抗体反应和的异质中和抗体.
结论:
- 一种结构导向的免疫信息学方法可以成功地针对特定的抗体结构类别.
- 这种范式使得免疫遗传学上多样化,但结构上保存的抗体能够得到.
- 这些发现推动了针对艾滋病毒和其他病原体的合理疫苗设计.
更多相关视频
09:07Single-cell Screening Method for the Selection and Recovery of Antibodies with Desired Specificities from Enriched Human Memory B Cell Populations
Published on: August 22, 2019
11.4K
13:14Generation of Discriminative Human Monoclonal Antibodies from Rare Antigen-specific B Cells Circulating in Blood
Published on: February 6, 2018
10.9K
相关概念视频
Diversity of Antigen Receptors
1.3K
Antigen receptors are essential components of the immune system crucial in defending the body against foreign invaders. These receptors are present on the surface of B and T cells, enabling them to recognize antigens and mount an appropriate immune response.
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
1.3K
Cross-reactivity
32.8K
Overview
32.8K
Antibody Structure
65.2K
Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
65.2K
Hybridoma Technology
17.1K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
17.1K
Antibody Structure and Classes
8.1K
Antibodies, also known as immunoglobulins, are produced by B cells in response to foreign substances, such as bacteria and viruses. These proteins are critical for recognizing and neutralizing these substances, protecting the body from potential harm.
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
8.1K
